Global microRNA profiling of well-differentiated small intestinal neuroendocrine tumors.
about
Small bowel neuroendocrine tumors: From pathophysiology to clinical approachIdentification of microRNAs regulating Escherichia coli F18 infection in Meishan weaned pigletsNoncoding RNAs in endocrine malignancyPredicting the survival of patients with small bowel neuroendocrine tumours: comparison of 3 systems.Primary Renal Carcinoid with Bilateral Multiple Clear Cell Papillary Renal Cell Carcinomas.Blood born miRNAs signatures that can serve as disease specific biomarkers are not significantly affected by overall fitness and exerciseMicroRNAs (miRNAs) as biomarker(s) for prognosis and diagnosis of gastrointestinal (GI) cancers.MicroRNA transcriptome in swine small intestine during weaning stress.Identification of candidate serum proteins for classifying well-differentiated small intestinal neuroendocrine tumorsSomatostatin Analogs Treated Small Intestinal Neuroendocrine Tumor Patients Circulating MicroRNAs.Consensus on biomarkers for neuroendocrine tumour diseaseDecoding the Molecular and Mutational Ambiguities of Gastroenteropancreatic Neuroendocrine Neoplasm Pathobiology.Alternative polyadenylation of tumor suppressor genes in small intestinal neuroendocrine tumors.Molecular biology of neuroendocrine tumors: from pathways to biomarkers and targets.Clinical application of microRNA testing in neuroendocrine tumors of the gastrointestinal tract.Epigenetic changes in gastroenteropancreatic neuroendocrine tumours.Neuroendocrine gastro-enteropancreatic tumors - from eminence based to evidence-based medicine - A Scandinavian view.Circulating miRNAs as biomarkers for endocrine disorders.Contribution of microRNA analysis to characterisation of pancreatic lesions: a review.NETs: organ-related epigenetic derangements and potential clinical applications.Genetics and epigenetics in small intestinal neuroendocrine tumours.Profiling of metastatic small intestine neuroendocrine tumors reveals characteristic miRNAs detectable in plasmaEpigenetics of gastroenteropancreatic neuroendocrine tumors: A clinicopathologic perspective.Molecular strategies in the management of bronchopulmonary and thymic neuroendocrine neoplasms.Synchronous multiple carcinoma with small intestine and pulmonary neuroendocrine involvement: A case report.Prognostic and predictive role of the PI3K-AKT-mTOR pathway in neuroendocrine neoplasms.The Treatment Landscape and New Opportunities of Molecular Targeted Therapies in Gastroenteropancreatic Neuroendocrine Tumors.Hsa-miR-202-3p, up-regulated in type 1 gastric neuroendocrine neoplasms, may target DUSP1.Molecular challenges of neuroendocrine tumors.Analysis of miR-96 and miR-133a Expression in Gastrointestinal Neuroendocrine Neoplasms.Measurement of circulating transcripts and gene cluster analysis predicts and defines therapeutic efficacy of peptide receptor radionuclide therapy (PRRT) in neuroendocrine tumors.MicroRNA analysis of gastroenteropancreatic neuroendocrine tumors and metastases.
P2860
Q26766650-6CEB3D23-5C8B-4BF1-8437-648BFB882BDAQ30827369-E76F3363-4694-4962-8B5E-BA01E6528533Q33577889-303D5370-D25C-40FB-9AC7-79C8C3CFB0EBQ33656484-F9033DC2-8E21-4C8D-936F-9855B08043AEQ33767898-24B5154D-238C-4BC1-9593-0B78D1863101Q33882686-0A9117A5-528D-4E20-BFC9-0FB9C3EB1A29Q33962495-66E1F82E-9A2B-43F5-A663-2CA8A1EFE265Q35048355-1157258E-FBFD-42D9-AB27-5EB3C404675FQ35055381-43BFD08D-D15E-43CB-A7FE-F02A446182D7Q35571226-BF64EC23-8A29-4D36-A6E7-71E507743B56Q37255681-3FC18A8E-7253-452B-80D0-FD6D202F60B4Q37634917-125C133A-E4FC-4A34-8C04-2589BB6138D7Q37715730-673D234B-2275-40B0-AB97-71992EF204D0Q38174516-74AC9548-E354-4DD8-80F2-C7F61C937B56Q38190817-D4F4A19D-B0D9-4B1C-BC31-E9EA86B8C723Q38272919-8B82559E-4F7D-4F87-9B49-903EE367E3ADQ38412071-7E664C69-BB4A-43F9-A6F5-FA8200B30E6AQ38503895-4B66249B-4031-4960-8890-5AA6AAB385D2Q38575189-14380980-84CB-428D-9122-2E9CA09F4459Q38841735-EFF232DD-6240-409D-B33F-841B1E27D468Q38866281-0CD24069-A206-41F0-AF15-7C081D84DA49Q41552378-8D8EC58C-C6B9-4838-93E8-BF6BB19782E9Q42115029-BD535415-3AFB-4DA8-A82E-CDFEBA6881D3Q45360690-7D2C5ABE-2B45-46F2-8ACE-DC6D53C14DE7Q47112388-2A81ED6D-DDF3-4B97-9DA0-9367F7AF8437Q47847243-216C5ED1-567A-426F-A926-D1167A9E393EQ48295398-22985A93-6BC9-4091-8D6B-2E5274D124E2Q49701576-EC593099-F790-4E7A-9BCA-03F0FA630201Q49875027-64FE565C-E323-45FE-B030-4E7F792CD459Q50069968-6B5B96DB-441D-4A79-BF59-9EFCA3B3854BQ50767864-1C8FC17E-2AA7-4A71-9245-FA83A3A0C523Q55452160-688E5779-FBB0-4186-9BE4-F2FD298D8397
P2860
Global microRNA profiling of well-differentiated small intestinal neuroendocrine tumors.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
name
Global microRNA profiling of well-differentiated small intestinal neuroendocrine tumors.
@ast
Global microRNA profiling of well-differentiated small intestinal neuroendocrine tumors.
@en
Global microRNA profiling of well-differentiated small intestinal neuroendocrine tumors.
@nl
type
label
Global microRNA profiling of well-differentiated small intestinal neuroendocrine tumors.
@ast
Global microRNA profiling of well-differentiated small intestinal neuroendocrine tumors.
@en
Global microRNA profiling of well-differentiated small intestinal neuroendocrine tumors.
@nl
prefLabel
Global microRNA profiling of well-differentiated small intestinal neuroendocrine tumors.
@ast
Global microRNA profiling of well-differentiated small intestinal neuroendocrine tumors.
@en
Global microRNA profiling of well-differentiated small intestinal neuroendocrine tumors.
@nl
P2093
P2860
P1433
P1476
Global microRNA profiling of well-differentiated small intestinal neuroendocrine tumors
@en
P2093
Ahmed Essaghir
Cécile Martijn
Kjell Oberg
Ricardo V Lloyd
Su-Chen Li
Valeria Giandomenico
P2860
P2888
P304
P356
10.1038/MODPATHOL.2012.216
P577
2013-01-18T00:00:00Z
P5875
P6179
1040867130